Pyros Pharms Company Profile
What is the competitive landscape for PYROS PHARMS
PYROS PHARMS has two approved drugs.
There are three US patents protecting PYROS PHARMS drugs.
Summary for Pyros Pharms
| US Patents: | 3 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Pyros Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pyros Pharms | VIGAFYDE | vigabatrin | SOLUTION;ORAL | 217684-001 | Jun 17, 2024 | RX | Yes | Yes | 12,016,857 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pyros Pharms | VIGAFYDE | vigabatrin | SOLUTION;ORAL | 217684-001 | Jun 17, 2024 | RX | Yes | Yes | 12,576,054 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pyros Pharms | VIGAFYDE | vigabatrin | SOLUTION;ORAL | 217684-001 | Jun 17, 2024 | RX | Yes | Yes | 12,290,499 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pyros Pharms | VIGPODER | vigabatrin | FOR SOLUTION;ORAL | 214961-001 | Jun 24, 2022 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Pyros Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2020039262 | ⤷ Start Trial |
| United Kingdom | 2591389 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2024058812 | ⤷ Start Trial |
| United Kingdom | 202103724 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
